Replimune Group GAAP EPS of -$0.90 misses by $0.11
Source: SeekingAlpha
2025-11-06 08:26:20 ET
More on Replimune Group
- Replimune: Acceptance Confirms Completeness, Not Approval (Rating Upgrade)
- Replimune: Further Uncertainty Of RP1 Warrants Move To 'Hold' Rating
- Replimune soars 108% on BLA resubmission acceptance of melanoma asset
- Replimune cut to Underweight at J.P. Morgan on further headline risk
- Seeking Alpha’s Quant Rating on Replimune Group
Read the full article on Seeking Alpha
For further details see:
Replimune Group GAAP EPS of -$0.90 misses by $0.11
Replimune Group Inc.
NASDAQ: REPL
REPL Trading
-1.05% G/L:
$8.51 Last:
892,705 Volume:
$8.67 Open:
REPL Latest News
February 03, 2026 08:00:00 am
Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
December 18, 2025 08:00:00 am
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
REPL Stock Data
$646,543,607
51,607,887
0.33%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Woburn
